SCHEMBL7669588

SCHEMBL7669588

CCCCCc1ccc(C(=O)Nc2ccc(S(=O)(=O)NCC(=O)O)cc2)cc1

nearest known ligand 0.66

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.59
TRPV1 Q8NER1 4/20 0.58
LMNA P02545 2/20 0.56
ALDH1A1 P00352 1/20 0.56
NPC1 O15118 1/20 0.55
GALR3 O60755 1/20 0.55
RAB9A P51151 1/20 0.55
PRMT1 Q99873 2/20 0.54
CA12 O43570 1/20 0.53
CA1 P00915 1/20 0.53
CA2 P00918 1/20 0.53
CA9 Q16790 1/20 0.53
MAPT P10636 1/20 0.50
MAPK1 P28482 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
NR1H4 Q96RI1 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7669110 0.99 KDM4E (0.58) KDM4ETRPV1LMNAALDH1A1NPC1
SCHEMBL7667917 0.99 KDM4E (0.58) KDM4ETRPV1LMNAALDH1A1NPC1
SCHEMBL7667904 0.99 KDM4E (0.58) KDM4ETRPV1LMNAALDH1A1NPC1
SCHEMBL7671765 0.92 ALDH1A1 (0.63) KDM4ETRPV1LMNAALDH1A1PRMT1
SCHEMBL7663470 0.87 LMNA (0.62) LMNAALDH1A1PRMT1MAPK1SMN1; SMN2
SCHEMBL7669959 0.85 KDM4E (0.53) KDM4ETRPV1LMNAALDH1A1NPC1
SCHEMBL7673461 0.84 KDM4E (0.52) KDM4ETRPV1LMNAALDH1A1NPC1
SCHEMBL7671606 0.84 KDM4E (0.52) KDM4ETRPV1LMNAALDH1A1NPC1
SCHEMBL7669245 0.84 KDM4E (0.52) KDM4ETRPV1LMNAALDH1A1NPC1
SCHEMBL5099330 0.82 MEN1 (0.62) KDM4ELMNAALDH1A1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6403644-B1 FOR PREVENTION AND/OR TREATMENT OF DISEASES INDUCED BY OVEREXPRESSION AND EXCESS ACTIVITY OF MATRIX METALLOPROTEINASE; FOR EXAMPLE, RHEUMATOID, ARTHROSTEITIS, UNUSUAL BONE RESORPTION, OSTEOPOROSIS, PERIODONTITIS ONO PHARMACEUTICAL CO., LTD. (JP) 2002-06-11 US claimed
EP-0757037-A2 Sulfonylamino acid derivatives as metalloproteinase inhibitors ONO PHARMACEUTICAL CO., LTD. (JP) 1997-02-05 EP claimed
US-6403644-B1 FOR PREVENTION AND/OR TREATMENT OF DISEASES INDUCED BY OVEREXPRESSION AND EXCESS ACTIVITY OF MATRIX METALLOPROTEINASE; FOR EXAMPLE, RHEUMATOID, ARTHROSTEITIS, UNUSUAL BONE RESORPTION, OSTEOPOROSIS, PERIODONTITIS ONO PHARMACEUTICAL CO., LTD. (JP) 2002-06-11 US disclosed
US-6177466-B1 Sulfonylamino acid derivatives ONO PHARMACEUTICAL CO., LTD. (JP) 2001-01-23 US disclosed
EP-0757037-A2 Sulfonylamino acid derivatives as metalloproteinase inhibitors ONO PHARMACEUTICAL CO., LTD. (JP) 1997-02-05 EP disclosed